A 9-year-old with fulminant myocarditis is in cardiogenic shock in the intensive care unit with low cardiac output and poor peripheral perfusion despite adequate preload. He is started on a dobutamine infusion. If perfusion does not improve and systemic vascular resistance remains high, which intravenous agent would be most appropriate to add for its combined positive inotropic and peripheral vasodilatory effects?